Clincosm LogoSign in Get a demo

Outcome of Transanal Specimen Extraction Surgery for Elderly Colorectal Cancer Patients

Sponsor
The Second Affiliated Hospital of Harbin Medical University (Other)
Overall Status
Completed
CT.gov ID
NCT05744362
Collaborator
(none)
1,395
Enrollment
1
Location
2
Actual Duration (Months)
696.1
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

Retrospective analysis of a cohort of elderly CRC patients (aged ≥ 65 years) underwent transanal-NOSES between August 2008 and February 2022 was constructed. Data were obtained from China NOSES Database (CNDB). The primary outcomes included time to first flatus, postoperative hospital stays, 30-day postoperative complication and hospital mortality. The secondary outcomes were overall survival (OS) and disease-free survival (DFS).

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1395 participants
    Observational Model:
    Case-Crossover
    Time Perspective:
    Retrospective
    Official Title:
    Outcome of Transanal Specimen Extraction Surgery for Elderly Colorectal Cancer Patients: a National Database Study in China of 1395 Cases
    Actual Study Start Date :
    Nov 1, 2022
    Actual Primary Completion Date :
    Dec 1, 2022
    Actual Study Completion Date :
    Jan 1, 2023

    Outcome Measures

    Primary Outcome Measures

    1. Overall survival [4-year]

      Time of death from any cause after survival

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    65 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:

    patients diagnosed as T1-4N0-2M0 colorectal cancer pathologically

    patients underwent transanal-NOSES

    patients aged 65 years or older

    Exclusion Criteria:

    patients with multiple primary colorectal cancer

    patients with total colectomy

    patients without complete data

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 The Second Affiliated Hospital of Harbin Medical University Harbin Heilongjiang China 150000

    Sponsors and Collaborators

    • The Second Affiliated Hospital of Harbin Medical University

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Zhang Hao, Clinical Professor, The Second Affiliated Hospital of Harbin Medical University
    ClinicalTrials.gov Identifier:
    NCT05744362
    Other Study ID Numbers:
    • KY2022-313
    First Posted:
    Feb 27, 2023
    Last Update Posted:
    Feb 27, 2023
    Last Verified:
    Dec 1, 2022
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Zhang Hao, Clinical Professor, The Second Affiliated Hospital of Harbin Medical University
    survival
    Additional relevant MeSH terms:
    Colorectal Neoplasms

    Study Results

    No Results Posted as of Feb 27, 2023